Advertisement

International Ophthalmology

, Volume 38, Issue 5, pp 1863–1869 | Cite as

Influence of glycosylated hemoglobin on the choroidal thickness

  • Nedime Sahinoglu-Keskek
  • Rana Altan-Yaycioglu
  • Handan Canan
  • Muge Coban-Karatas
Original Paper
  • 81 Downloads

Abstract

Purpose

The aim of the study reported here was to assess the influence of serum HbA1c levels on foveal choroidal thickness in diabetic patients.

Methods

A total of 122 eyes from 122 patients who had type 2 DM were studied in this prospective, cross-sectional study. Patients were divided into three groups: 43 patients (43 eyes) without diabetic retinopathy (NDR), 39 patients (39 eyes) with diabetic retinopathy and no macular edema (DR/ME−), 40 patients (40 eyes) with diabetic retinopathy and macular edema (DR/ME+). Central foveal thicknesses and subfoveal choroidal thicknesses were noted. Subfoveal choroidal thickness measurement was taken perpendicularly from the outer part of the retinal pigment epithelial layer to the line corresponding to the choroidal–scleral junction. Serum glycosylated hemoglobin (HbA1c) levels were evaluated.

Results

No significant differences in age, gender, pseudophakia were observed between the groups. There was no significant difference in HbA1c value among the three diabetic groups. Mean foveal choroidal thickness was 270.09 ± 42.41 in NDR group, 243.18 ± 30.21 in DR/ME− group and 250.90 ± 40.06 in DR/ME+ group. Mean foveal choroidal thickness in NDR group was significantly different from DR/ME− group. There was no statistically significant difference between the other groups among foveal choroidal thicknesses. There was no correlation between HbA1c and foveal choroidal thickness. Multiple regression analyses of two diabetic retinopathy groups showed no significant correlation between foveal choroidal thickness and HbA1c and also no significant correlation between foveal choroidal thickness and duration of diabetes.

Conclusions

Serum HbA1c levels were not correlated with foveal choroidal thickness. Choroidal thickness is effected by several factors as axial length, age and systemic diseases.

Keywords

Choroidal thickness Diabetic retinopathy Glycosylated hemoglobin Macular edema 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Ferris FL, Davis MD, Aiello LM (1999) Treatment of diabetic retinopathy. N Engl J Med 341:667–678CrossRefGoogle Scholar
  2. 2.
    Ferris FL (1993) How effective are treatments for diabetic retinopathy? JAMA 269:1290–1291CrossRefPubMedCentralGoogle Scholar
  3. 3.
    McLeod DS, Lutty GA (1994) High-resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci 35:3799–3811PubMedPubMedCentralGoogle Scholar
  4. 4.
    Unsal E, Eltutar K, Zirtiloglu S et al (2014) Choroidal thickness in patients with diabetic retinopathy. Clin Ophthalmol 8:637–642CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Regatieri CV, Branchini L, Carmody J et al (2012) Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina 32:563–568CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Yülek F, Uğurlu N, Önal ED et al (2014) Choroidal changes and duration of diabetes. Semin Ophthalmol 29:80–84CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Akay F, Gundogan FC, Yolcu U, Toyran S, Uzun S (2016) Choroidal thickness in systemic arterial hypertension. Eur J Ophthalmol 26:152–157CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Wong IY, Wong RL, Zhao P, Lai WW (2013) Choroidal thickness in relation to hypercholesterolemia on enhanced depth imaging optical coherence tomography. Retina 33:423–428CrossRefPubMedCentralGoogle Scholar
  9. 9.
    Ahsan H (2015) Diabetic retinopathy—biomolecules and multiple pathophysiology. Diabetes Metab Syndr 9:51–54CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Report of a World Health Organization Consultation (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 93:299–309CrossRefGoogle Scholar
  11. 11.
    Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556–564CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Varma R, Bressler NM, Doan QV et al (2014) Prevalence of and risk factors for diabetic macular edema in the United States. JAMA Ophthalmol 132:1334–1340CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Alm A, Bill A (1992) Ocular circulation. Adler’s physiology of the eye, 9th edn. Mosby, St Louis, pp 198–227Google Scholar
  14. 14.
    American Diabetes Association (2010) Standards of medical care in diabetes-2010. Diabetes Care 33:692CrossRefGoogle Scholar
  15. 15.
    Pan J, Li Q, Zhang L et al (2014) Serum glycatedalbümin predicts the progression of diabetic retinopathy—a five year retrospective longitudinal study. J Diabetes Complications 28:772–778CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Nagaoka T, Kitaya N, Sugawara R et al (2004) Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol 88:1060–1063CrossRefPubMedCentralGoogle Scholar
  17. 17.
    Lee SW, Kim HC, Lee YH et al (2017) Association between HbA1c and carotid atherosclerosis among elderly Koreans with normal fasting glucose. PLoS ONE 12:e0171761CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Jones CD, Greenwood RH, Misra A, Bachmann MO (2012) Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care 35:592–596CrossRefPubMedCentralGoogle Scholar
  19. 19.
    Yolcu U, Çağıltay E, Toyran S et al (2016) Choroidal and macular thickness changes in type 1 diabetes mellitus patients without diabetic retinopathy. Postgrad Med 128:755–760CrossRefPubMedCentralGoogle Scholar
  20. 20.
    Kase S, Endo H, Yokoi M et al (2016) Choroidal thickness in diabetic retinopathy in relation to long-term systemic treatments for diabetes mellitus. Eur J Ophthalmol 26:158–162CrossRefPubMedCentralGoogle Scholar
  21. 21.
    Xu J, Xu L, Du KF et al (2013) Subfoveal choroidal thickness in diabetes and diabetic retinopathy. Ophthalmology 120:2023–2028CrossRefPubMedCentralGoogle Scholar
  22. 22.
    Okamoto M, Matsuura T, Ogata N (2016) Effects of panretinal photocoagulation on choroidal thickness and choroidal blood flow in patients with severe nonproliferative diabetic retinopathy. Retina 36:805–811CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2017

Authors and Affiliations

  1. 1.Adana Research and Training CenterBaskent University Faculty of MedicineAdanaTurkey

Personalised recommendations